On March 10, 2023, Virax Biolabs Group Limited closed the transaction. The company has received funding pursuant to Regulation D from one investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7911 USD | -4.69% | +4.78% | -45.82% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.82% | 1.96M | |
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |
- Stock Market
- Equities
- VRAX Stock
- News Virax Biolabs Group Limited
- Virax Biolabs Group Limited announced that it has received $4.000001 million in funding